U.S. market Closed. Opens in 8 hours 14 minutes

TVGN | Tevogen Bio Holdings Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
RevenueN/AN/AN/A
Cost of RevenueN/AN/AN/A
Gross ProfitN/AN/AN/A
Operating Expenses2.27M953.08K4.62M
Selling, General & Admin2.27M953.08K1.66M
Research & Development4.40K5.77M2.96M
Other Operating Expenses-882.00-7.38M-10.38M
Operating Income-2.27M-13.72M-4.62M
Other Expenses / Income2.46M5.36M-10.38M
Before Tax Income-67.33K4.41M-15.60M
Income Tax Expenses255.87K-230.82K-9.78M
Net Income-67.33K4.41M-15.60M
Interest Expenses256.03KN/A598.50K
Basic Shares Outstanding165.42M120.00M120.00M
Diluted Shares Outstanding165.42M120.00M120.00M
EBITDA-2.27M-953.08K-14.99M
EBITDA Margin0.00%0.00%0.00%
EBIT444.57K4.18M-24.78M
EBIT Margin0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙